CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Autres langues Chongqing Zhifei Biological Products Co., Ltd.

Actions

300122

CNE100000V20

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
34,83 ^CNY	+1,81%		-13,98%	-43,00%

23/04	Les bénéfices de Chongqing Zhifei Biological Products pour 2023 augmentent de 7% ; les actions chutent de 12%.	MT
22/04	Chongqing Zhifei Biological Products Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%	23/04
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.	28/03
Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback announced on February 22, 2024, has closed with 6,210,253 shares, for CNY 300.01 million.	28/03
Chongqing Zhifei Biological Products Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	22/02
Chongqing Zhifei Biological Products Co., Ltd. authorizes a Buyback Plan.	22/02
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	11/01
Wordt de CSI A50 de beste Chinese index?	05/01
¿Se convertirá el CSI A50 en el mejor índice chino?	03/01
Zhifei Biological Products to Acquire Local Biopharma Firm, Expanding Into Metabolic Disease Treatments	27/11
Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.	23/11
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Middle East Conflict Weighs on Exchange-Traded Funds, Equity Futures Pre-Bell Monday	09/10/23
GSK Signs Distribution Deal With China's Zhifei for Shingles Vaccine	09/10/23
Chongqing Zhifei Biological Enters Exclusive Distribution Deal With GSK	09/10/23
MIDDAY BRIEFING - Unternehmen und Märkte	09/10/23
Trending : GSK Signs $3 Billion Shingles Vaccine Deal in China	09/10/23
GSK schließt Abnahmevertrag für Gürtelrose-Impfstoff in China über 2,5 Mrd Pfund	09/10/23
GSK Strikes $3.06 Billion Shingles Vaccine Deal With China's Zhifei -- Update	09/10/23
European Midday Briefing : Oil Surges, Stocks Fall on Middle East Conflict	09/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Chongqing Zhifei Biological Products Co., Ltd.

Actions

300122

CNE100000V20

Autres langues

Filtres